|
Breaking
the faith
Inspite of a rapidly growing pharma and health industry, several
internationally banned drugs are easily available in the country.
Sushmi Dey reveals more on the controversy
Dabur
Pharma divests its stake to Fresenius Kabi
The Burman family, promoters of the Dabur Group, has decided
to divest its entire stake in Dabur Pharma to Fresenius Kabi,
a business segment of Fresenius SE, a Euro 11.4 billion German
multinational with business interests across the global healthcare
space, at a price of Rs 76.50 per share.
SIRO
acquires Omega Mediation
SIRO Clinpharm announced the signing of an acquisition agreement
of Omega Mediation Group, a midsized European CRO, for an
undisclosed amount in an all cash deal.
Aiming
at the European market
Rahul Sehgal, President, Nestor Pharmaceuticals, reveals to
Suja Nair the details of the recent MHRA approval that the
company received in UK to market its products
Ranbaxy
and Orchid announce strategic business alliance
Ranbaxy Laboratories and Orchid Chemicals and Pharmaceuticals
announced that they have entered into a business alliance
agreement involving multiple geographies and therapies for
both finished dosage formulations and active pharmaceutical
ingredients.
Claris
Lifesciences gets US FDA approval
Claris Lifesciences has announced that it has received US
FDA approval for three injectables products-ciproflaxacin
(anti-infective), metronidazole (anti-infective) and ondansetron
(anti-emetic).
Settling
it out
Of late, pharmaceutical companies seem to be resorting to
out-of-court settlements, in a bid to put an end to time consuming
legal hassles and piling up bills. Suja Nair analyses recent
out-of-court settlements
NCRM
starts PhD programme in stem cell research
Nichi-In Centre for Regenerative Medicine (NCRM), Chennai,
in affiliation with Acharya Nagarjuna University, Guntur,
launched an academic programme of doctorate level research
in stem cell research for postgraduates in life sciences or
graduates in medical, veterinary or dental medicine.
UK
firms 'hungry' to tie up with India
At a recent seminar organised in Mumbai by UK Trade and Investment,
a dozen odd UK-base firms, came on a mission to search for
partners.
Italy-India
forum focuses on technology co-operation
Italian Trade Commission (ICE), in association with Federation
of Indian Chambers of Commerce and Industry(FICCI), recently
organised Italy-India fora at New Delhi and Bangalore.
Events
Indian
biotech booms at Bangalore Bio
The three pronged strategy of innovate, educate and partner
echoed at Bangalore Bio 2008. Arshiya Khan reports
15
percent of global business will come to India
From starting India's first clinical research training institute
to introducing the concept of Site Management Organisations
(SMOs) in India, Shiv Raman Dugal, Chairman, Institute of
Clinical Research (India) (ICRI) has seen the evolution of
this industry. Excerpts from a conversation with Arshiya Khan
|
